GoI to increase production of Amphotericin B amid rising cases of Mucormycosis
12 May, 2021 | Vaishali Sharma
Amid a sudden increase in demand observed in some states for Amphotericin B which is being prescribed by physicians to patients suffering from Mucormycosis, a post COVID complication, the Governmen...
Amid a sudden increase in demand observed in some states for Amphotericin B which is being prescribed by physicians to patients suffering from Mucormycosis, a post COVID complication, the Government of India is engaging with the manufacturers to ramp up production of the drug, said the Ministry of Chemicals and Fertilizers on Wednesday.
The ministry further stated that the supply position is expected to improve with extra imports of this drug and an increase in its production domestically.
After reviewing the stock position with the manufacturers/importers, and the demand pattern of Amphotericin B the Department of Pharma, had on May 11, 2021, allocated this drug amongst the States/UTs based on expected supply that will be available from May 10 to May 31, 2021, stated the ministry.
The arrangements for supply will be monitored by National Pharmaceuticals Pricing Authority (NPPA), said the ministry.